Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1Phase 1/2 1

Status

Unknown 2Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 4

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 12Solid Tumor 9Solid Tumors 6Advanced Solid Tumors 5Advanced Solid Tumor 4Advanced Solid Tumour 2Solitary Fibrous Tumor, Pleural 1Solid Tumor Cancer 1Resectable Colon Cancer 1Mesothelioma, Malignant 1MSI-H Colorectal Cancer 1Locally Advanced and Metastatic Solid Tumors 1DMMR Colorectal Cancer 1Childhood Solid Tumor 1Advanced Solid Tumor Cancer 1Advanced Malignant Solid Tumors 1Adult 1

Interventions

Injections 26toripalimab 17pembrolizumab 17tislelizumab 12Gemcitabine 8Cisplatin 7spartalizumab 6atezolizumab 6Irinotecan 6Carboplatin 6Paclitaxel 5Oxaliplatin 5Nivolumab 5Leucovorin 5Fluorouracil 5camrelizumab 4Pemetrexed 4Docetaxel 4Cetuximab 4Capecitabine 4trastuzumab deruxtecan 3sintilimab 3olaparib 3lenvatinib 3cediranib 3PM 01183 3Drug Therapy 3Cyclophosphamide 3Bevacizumab 3Albumin-Bound Paclitaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Advanced Solid Tumor × Capecitabine × Other solid neoplasm × Clear all
NCT06139211 2024-12-20

A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors

Shanghai Junshi Bioscience Co., Ltd.

Phase 1/2 Recruiting
186 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT06446388 2024-06-06

Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors

Qilu Pharmaceutical Co., Ltd.

Phase 2 Not yet recruiting
360 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT05700084 2024-04-19

Tolerability and Bioavailability of Utidelone Capsule in Patients With Advanced Solid Tumors

Beijing Biostar Pharmaceuticals Co., Ltd.

Phase 1 Unknown
84 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT05344742 2022-04-25

A Study of Mitoxantrone Hydrochloride Liposome Injection Combination Therapy in Chinese Patients With Advanced Solid Tumors

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Unknown
116 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡